<DOC>
	<DOCNO>NCT02344316</DOCNO>
	<brief_summary>Migraine adolescent common effective safe preventive treatment need . This pilot randomize control trial melatonin versus placebo migraine prevention adolescents 12-17 year old .</brief_summary>
	<brief_title>Bringing Relief Adolescents Naturally Using Melatonin Migraine</brief_title>
	<detailed_description>This pilot randomize control trial melatonin vs. placebo migraine prevention adolescents 12-17 year old . The main goal pilot study estimate variance outcome measure help plan future fully power study . Participants person enrollment visit , follow phone follow visit headache diary data collection via smart phone internet .</detailed_description>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Melatonin</mesh_term>
	<criteria>1 . Age 1217 year weight ≥40 kg , allow consistent dose participant melatonin dose find effective adult 2 . Resides California 3 . Headache fulfill International Classification Headache Disorders , Third Edition ( beta version ) 33 criterion episodic migraine ( without aura ) adolescents 4 . Has experience episodic headache least six month 5 . Experiences 614 day migraine/migrainous headache per month baseline ( cutoff chronic migraine ≥15 days/month ) 6 . Developmentally able provide ageappropriate level assent 7 . Has parent/guardian capable give write informed consent 8 . Has daily access smartphone order able complete daily study procedure diary completion , receive text reminder 9 . Subject parent agree adolescent use overthecounter melatonin , another migraine preventive medication , participate study 10 . Participant least one parent speak English 1 . Currently ( within last 4 week ) use medication device migraine preventive property : i.e . topiramate , amitriptyline , nortriptyline , propranolol , metoprolol , sodium valproate , gabapentin , flunarizine , methysergide , riboflavin , butterbur , coenzyme Q10 , Cefaly TENS device . For onabotulinum toxin , least three month 2 . Use sleep medication sedate medication , benzodiazepine , trazodone , melatonin receptor agonists 3 . History allergy adverse event previous use exogenous melatonin 4 . Previous ineffective trial melatonin 3 mg nightly migraine prevention , trial duration least three month duration 5 . Inability swallow pill , inability persists instruction pillswallowing technique 6 . History epilepsy seizure 7 . Overuse acute headache medication , wherein medication overuse defined33 ≥4 day per month barbiturate contain compound , ≥10 day per month opioid contain compound , ≥10 day per month triptans ergotcontaining compound . Those use nonspecific analgesic ≥15 day per month would also exclude 8 . Adolescent cognitive capacity give verbal assent participate , investigator think adolescent cognitive capacity complete diary , even parental assistance 9 . For female : Pregnancy , lactate plan become pregnant study . For male : planning father child study 10 . Abnormal neurologic examination finding 11 . Serious medical illness kind ; seriousness judge investigator 12 . The investigator think participant comply study procedure , think medically appropriate participant study</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>